Institution statistics

ASSISTANCE PUBLIQUE - HOPITAUX DE PARIS - France

Ranking results:

Past rankings:

2017
Criterium:	Position:
Overall Score:	100-200
Total Project Funding per Partner:	200-300
Total Number of Projects:	200-300
Networking Rank (Reputation):	100-200
2016
Criterium:	Position:
Overall Score:	> 1000
Networking Rank (Reputation):	> 1000
2015
Criterium:	Position:
Overall Score:	600-700
Total Project Funding per Partner:	400-500
Total Number of Projects:	400-500
Networking Rank (Reputation):	300-400
Partner Constancy:	300-400
Project Leadership Index:	500-600
2014
Criterium:	Position:
Overall Score:	> 1000
Networking Rank (Reputation):	900-1000
2013
Criterium:	Position:
Overall Score:	500-600
Total Project Funding:	100-200
Total Project Funding per Partner:	200-300
Total Number of Projects:	64
Partner Constancy:	50
Project Leadership Index:	69
Diversity Index:	41
2012
Criterium:	Position:
Overall Score:	400-500
Total Project Funding:	100-200
Total Project Funding per Partner:	100-200
Total Number of Projects:	61
Networking Rank (Reputation):	200-300
Networking Rank (Reputation):	200-300
Partner Constancy:	43
Project Leadership Index:	66
Diversity Index:	60
2011
Criterium:	Position:
Overall Score:	> 1000
Total Project Funding:	200-300
Total Project Funding per Partner:	200-300
Total Number of Projects:	300-400
Networking Rank (Reputation):	300-400
Partner Constancy:	200-300
Project Leadership Index:	> 1000
Diversity Index:	> 1000
2010
Criterium:	Position:
Overall Score:	700-800
Total Project Funding:	200-300
Total Project Funding per Partner:	400-500
Total Number of Projects:	600-700
Networking Rank (Reputation):	400-500
Partner Constancy:	300-400
Project Leadership Index:	300-400
Diversity Index:	> 1000
2009
Criterium:	Position:
Overall Score:	300-400
Total Project Funding:	400-500
Total Project Funding per Partner:	300-400
Total Number of Projects:	300-400
Networking Rank (Reputation):	300-400
Partner Constancy:	> 1000
Project Leadership Index:	300-400
Diversity Index:	> 1000
2008
Criterium:	Position:
Overall Score:	600-700
Total Project Funding:	400-500
Total Project Funding per Partner:	300-400
Total Number of Projects:	300-400
Networking Rank (Reputation):	400-500
Partner Constancy:	> 1000
Project Leadership Index:	> 1000
Diversity Index:	400-500
2007
Criterium:	Position:
Overall Score:	> 1000
Total Project Funding:	200-300
Total Project Funding per Partner:	300-400
Total Number of Projects:	800-900
Networking Rank (Reputation):	500-600
Partner Constancy:	> 1000
Project Leadership Index:	> 1000
Diversity Index:	> 1000

Ranking timeline:

European project participation (2000-01-01 - 2018-12-31 ):

Performance:

Funding:

Total funding allocated to projects this organisation participated or coordinated

Funding per Partner:

Since 2014 individual funding per partner. If data is not available at CORDIS: total funding / No of participants.

Projects:

Leadership:

Total number of projects: 144
As coordinator: 9
As participant: 135
Sole participant: 0
Coordinator / Participant Ratio: 0.07^*

^*Ratio includes only projects with > 2 partners

Summary:

	Total project funding [€]:			Projects [No]:
Year:	coordinator^*	participant^*	per partner	as coordinator	as participant
2018	0	76.647.443	4.853.351		11
2017	6.189.570	82.236.366	4.139.822	1	10
2016	0	11.598.619	772.835		3
2015	0	40.823.453	2.529.291		7
2014	4.500.962	5.206.530	1.468.803	1	3
2013	0	88.682.255	4.213.364		10
2012	5.900.000	62.332.099	4.348.146	1	10
2011	0	78.648.314	2.043.179		11
2010	5.983.478	49.989.501	2.785.675	1	6
2009	2.989.154	24.922.118	1.941.656	1	6
2008	0	26.208.018	2.081.005		8
2007	0	21.207.358	763.160		2
2006	0	57.771.199	3.541.212		7
2005	0	2.722.199	117.109		3
2004	0	13.004.284	634.946		4
2003	1.399.714	7.493.889	1.013.486	1	8
2002	4.225.544	14.120.850	1.783.614	3	10
2001	0	11.200.747	1.710.201		7
2000	0	13.704.602	1.535.402		9

^*n.b.: These numbers represent the total amount of funds allocated to projects this institution has participated in, not the funding allocated to this institution

Networking:

Partners:

Institution:	Projects [No]:
INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE	44
UNIVERSITY COLLEGE LONDON	37
KAROLINSKA INSTITUTE	21
STICHTING KATHOLIEKE UNIVERSITEIT	18
KATHOLIEKE UNIVERSITEIT LEUVEN	16
KING'S COLLEGE LONDON	14
UNIVERSITAET ULM	14
UNIVERSITY OF NEWCASTLE UPON TYNE	14
CHARITE UNIVERSITAETSMEDIZIN BERLIN	12
ERASMUS UNIVERSITAIR MEDISCH CENTRUM ROTTERDAM	12
INSERM TRANSFERT	11
COMMISSARIAT A L'ENERGIE ATOMIQUE	10
SERVICIO MADRILENO DE SALUD	10
UNIVERSITA DEGLI STUDI DI PADOVA	10
UNIVERSITAIR MEDISCH CENTRUM UTRECHT	10
CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE	9
LUDWIG MAXIMILIANS UNIVERSITAET MUENCHEN	9
REGION HOVEDSTADEN	9
CENTRE HOSPITALIER UNIVERSITAIRE DE MONTPELLIER	8
CENTRE HOSPITALIER UNIVERSITAIRE DE NANTES	8
ECRIN EUROPEAN CLINICAL RESEARCH INFRASTRUCTURE NETWORK	8
IMPERIAL COLLEGE OF SCIENCE TECHNOLOGY AND MEDICINE	8
ISTITUTO SUPERIORE DI SANITA	8
MEDIZINISCHE HOCHSCHULE HANNOVER	8
QUEEN MARY AND WESTFIELD COLLEGE UNIVERSITY OF LONDON	8
THE CHANCELLOR MASTERS AND SCHOLARS OF THE UNIVERSITY OF OXFORD	8
THE UNIVERSITY OF LIVERPOOL	8
UNIVERSITA CATTOLICA DEL SACRO CUORE	8
UNIVERSITA DEGLI STUDI DI TORINO	8
UNIVERSITY OF COPENHAGEN	8
UNIVERSITY OF DUNDEE	8
ACADEMISCH MEDISCH CENTRUM BIJ DE UNIVERSITEIT VAN AMSTERDAM	7
ASSOCIATION POUR LA RECHERCHE SUR LES TRANSPLANTATIONS MEDULLAIRES	7
CENTRE HOSPITALIER REGIONAL ET UNIVERSITAIRE DE LILLE	7
HEINRICHHEINEUNIVERSITAET DUESSELDORF	7
HELSINKI UNIVERSITY CENTRAL HOSPITAL	7
INSTITUT CATALA DE LA SALUT	7
OSPEDALE PEDIATRICO BAMBINO GESU	7
THE CHANCELLOR MASTERS AND SCHOLARS OF THE UNIVERSITY OF CAMBRIDGE	7
UNIVERSITE DE GENEVE	7
UNIVERSITY OF BOLOGNA	7
WESTFAELISCHE WILHELMSUNIVERSITAET MUENSTER	7
ACADEMISCH ZIEKENHUIS BIJ DE UNIVERSITEIT VAN AMSTERDAM	6
ACADEMISCH ZIEKENHUIS GRONINGEN	6
CENTRE HOSPITALIER UNIVERSITAIRE DE TOULOUSE	6
CONSORCI INSTITUT D'INVESTIGACIONS BIOMEDIQUES AUGUST PI I SUNYER	6
GABO:MI GESELLSCHAFT FUR ABLAUFORGANISATION:MILLIARIUM MBH & CO KG GAB O	6
GENETHON	6
INSTITUT PASTEUR	6
LUNDS UNIVERSITET	6
MEDIZINISCHE UNIVERSITAET WIEN	6
STATENS SERUM INSTITUT	6
THE UNIVERSITY OF SHEFFIELD	6
UNIVERSITAETSKLINIKUM FREIBURG	6
UNIVERSITE DE LIEGE	6
UNIVERSITY OF BIRMINGHAM	6
UNIVERSITY OF GLASGOW	6
UNIVERSITY OF MANCHESTER	6
UPPSALA UNIVERSITET	6
EBERHARD KARLS UNIVERSITAET TUEBINGEN	5
FUNDACIO HOSPITAL UNIVERSITARI VALL D'HEBRON INSTITUT DE RECERCA	5
HLA ET MEDECINE	5
HOSPICES CIVILS DE LYON	5
LEIDEN UNIVERSITY	5
LEIDEN UNIVERSITY MEDICAL CENTER	5
MEDICAL RESEARCH COUNCIL	5
NATIONAL AND KAPODISTRIAN UNIVERSITY OF ATHENS	5
THE UNIVERSITY OF EDINBURGH	5
THE UNIVERSITY OF MILANO	5
THE UNIVERSITY OF NOTTINGHAM	5
UNIVERSIDAD COMPLUTENSE DE MADRID	5
UNIVERSITA DEGLI STUDI DI ROMA TOR VERGATA	5
UNIVERSITAET BERN	5
UNIVERSITAET LEIPZIG	5
UNIVERSITAET ZUERICH	5
UNIVERSITAETSKLINIKUM HEIDELBERG	5
UNIVERSITE DE PARIS VII DENIS DIDEROT	5
UNIVERSITY OF HELSINKI	5
UNIVERSITY OF LEEDS	5
UNIVERSITY OF TORINO	5
UNIVERSITY OF WALES CARDIFF	5
VIB	5
AGENCIA ESTATAL CONSEJO SUPERIOR DE INVESTIGACIONES CIENTIFICAS	4
CENTRO S GIOVANNI DI DIO FATEBENEFRATELLI ISTITUTO DI RICOVERO E CURA A CARATTERE SCIENTIFICO	4
CONSIGLIO NAZIONALE DELLE RICERCHE	4
DEUTSCHES KREBSFORSCHUNGSZENTRUM	4
EIDGENOESSISCHE TECHNISCHE HOCHSCHULE ZUERICH	4
ETABLISSEMENT FRANCAIS DU SANG	4
FUNDACIO PRIVADA CLINIC PER A LA RECERCA BIOMEDICA	4
GENOME RESEARCH	4
GOETEBORGS UNIVERSITET	4
HOSPITAL CLINIC BARCELONA	4
INSTITUT GUSTAVE ROUSSY	4
INSTITUT PAOLI CALMETTES CENTRE REGIONAL DE LUTTRE CONTRE LE CANCER	4
ISTITUTO DI RICERCHE FARMACOLOGICHE MARIO NEGRI	4
ISTITUTO GIANNINA GASLINI	4
ISTITUTO ORTOPEDICO RIZZOLI	4
NATIONAL INSTITUTE OF PUBLIC HEALTH	4
NATIONAL UNIVERSITY OF IRELAND GALWAY	4
RUPRECHT KARLS UNIVERSITAET HEIDELBERG	4

Constancy:

Total number of partners:2278

Partner loyalty:
Frequent Partner: (> 2 projects): 987
Rare Partner: 1291

Frequent / Rare Partner Ratio: 0.76

Diversity:

Subjects:

Subject:	No:
HEALTH	76
MEDICINE	76
MEDICINE, HEALTH	66
LIFE SCIENCES	58
SCIENTIFIC RESEARCH	35
SOCIAL ASPECTS	29
BIOTECHNOLOGY	18
MEDICINE AND HEALTH	15
MEDICAL BIOTECHNOLOGY	14
SAFETY	8
ENVIRONMENTAL PROTECTION	7
INFORMATION SYSTEMS	6
INFORMATION PROCESSING	6
POLICIES	5
INFORMATION PROCESSING, INFORMATION SYSTEMS	4
COORDINATION, COOPERATION	4
INNOVATION, TECHNOLOGY TRANSFER	4
COOPERATION	4
WASTE MANAGEMENT	4
TECHNOLOGY TRANSFER	4
COORDINATION	4
INNOVATION	4
ECONOMIC ASPECTS	3
REGULATIONS	3
LEGISLATION, REGULATIONS	3
TELECOMMUNICATIONS	3
LEGISLATION	3
HEALTHCARE DELIVERY/SERVICES	2
REGIONAL DEVELOPMENT	2
INDUSTRIAL MANUFACTURE	2
MICROELECTRONICS	1
AGRICULTURE	1
FORECASTING	1
RESEARCH ETHICS	1
ELECTRONICS	1
ELECTRONICS, MICROELECTRONICS	1
FOOD	1
SUSTAINABLE DEVELOPMENT	1

Diversity index:0.23

Categories:

Category:	No:
BIOLOGICAL SCIENCES	91
RTD HORIZONTAL TOPICS	43
SOCIAL AND ECONOMIC CONCERNS	31
PROTECTING MAN AND HIS ENVIRON	12
INDUSTRY AND TECHNOLOGY	8
AGRICULTURE AND MARINE RESOURC	1

Project overview:

Start date	Project	acronym	role	funding	partners
2018-06-01	Network Of practitioners For Emergency medicAl systems and cRitical care	NO FEAR	participant	3.495.958	18
2018-05-01	Immunome project consortium for AutoInflammatory Disorders	ImmunAID	participant	15.835.851	24
2018-04-01	Improving the care of patients suffering from acute or chronic pain	IMI-PainCare	participant	11.225.271	40
2018-01-01	Optimizing response to Li treatment through personalized evaluation of individuals with bipolar I disorder: the R-LiNK initiative	R-LiNK	participant	7.702.532	21
2018-01-01	Adeno-Associated Virus Vector-Mediated Liver Gene Therapy for Crigler-Najjar Syndrome	CureCN	participant	6.249.104	11
2018-01-01	Infradev - European Paediatric Translational Research Infrastructure	ID-EPTRI	participant	3.000.000	25
2018-01-01	Stem-cell based gene therapy for recombination deficient SCID (RECOMB)	RECOMB	participant	5.990.460	17
2018-01-01	Personalised maxillofacial bone regeneration	MAXIBONE	participant	5.949.665	12
2018-01-01	Immune Signatures for Therapy Stratification in Major Mood Disorders	MOODSTRATIFICATION	participant	5.963.750	12
2018-01-01	The EUropean TRAnsplantation and INnovation (EU-TRAIN) consortium for improving diagnosis and risk stratification in kidney transplant patients	EU-TRAIN	participant	6.641.546	12
2018-01-01	Improved Methods and Actionable Tools for Enhancing Health Technology Assessment	IMPACT HTA	participant	4.593.306	15
2017-12-01	Repurposing of carbamazepine for treatment of skeletal dysplasia	MCDS-Therapy	participant	5.697.391	10
2017-11-01	Liver Investigation: Testing Marker Utility in Steatohepatitis	LITMUS	participant	15.797.881	47
2017-09-01	An INtegrated next generation PREParedness programme for improving effective inter-organisational response capacity in complex environments of disasters and causes of crises	IN-PREP	participant	7.999.556	20
2017-09-01	Targeting the metabolism-immune system connections in Cancer	META-CAN	participant	3.831.958	10
2017-06-01	PAN EBOLA VACCINE INNOVATIVE APPROACH	PEVIA	coordinator	6.189.570	13
2017-01-10	Healthcare Alliance for Resourceful Medicines Offensive against Neoplasms in HematologY	HARMONY	participant	20.200.000	44
2017-01-01	Evaluating a Combination of Immune-based Therapies to Achieve a Functional Cure of HIV Infection	HIVACAR	participant	6.685.111	14
2017-01-01	SIMVASTATIN AND RIFAXIMIN AS NEW THERAPY FOR PATIENTS WITH DECOMPENSATED CIRRHOSIS	LIVERHOPE	participant	5.998.800	16
2017-01-01	Development of DIALIVE, a novel Liver Dialysis Device for the treatment of patients with Acute on Chronic Liver Failure (ACLF)	ALIVER	participant	6.478.738	11
2017-01-01	3-O-sulfated heparan sulfate translocation in altered membrane biology: A newstrategy for early population screening and halting Alzheimer’s neurodegeneration	ArrestAD	participant	3.991.096	8
2017-01-01	REgenerative therapy of intervertebral disc: a double blind phase 2b trial of intradiscal injection of mesenchymal stromal cells in degenerative disc disease of the lomber SPINE unresponsive to conventional therapy	RESPINE	participant	5.555.836	14
2016-10-01	Expanding and extending gene therapy of monogenic diseases of the haematopoietic system	GENE FOR CURE	participant	2.445.268	2
2016-02-01	Decision Support and Information Management System for Breast Cancer	DESIREE	participant	3.340.720	12
2016-01-01	Imaging the Force of Cancer	FORCE	participant	5.812.631	16
2015-11-01	EVA - patient ventilation beyond limits	EVA	participant	1.890.000	4
2015-09-01	REgenerative Stem cell therapy for STroke in Europe	RESSTORE	participant	6.338.259	30
2015-05-01	Application of omics-based strategies for improved diagnosis and treatment of endocrine hypertension	ENSAT-HT	participant	7.607.337	13
2015-05-01	Clinical evaluation of carbons of controlled porosity as a new therapeutic for the treatment of liver cirrhosis and non-alcoholic fatty liver disease.	CARBALIVE	participant	5.913.080	14
2015-05-01	I-MOVE+ Integrated Monitoring of Vaccines Effects in Europe: a platform to measure and compare effectiveness and impact of influenza and pneumococcal vaccines and vaccination strategies in the elderly	I-MOVE-plus	participant	7.482.729	25
2015-05-01	A EUropean study on effectiveness and sustainability of current Cardiac Rehabilitation programmes in the Elderly	EU-CaRE	participant	5.593.049	10
2015-01-01	Clinical trial of autologous adipose-derived mesenchymal stromal cells (ASC) in the treatment of mild to moderate osteoarthritis	ADIPOA2	participant	5.999.000	18
2014-11-01	Prevention and Management of High Threat Pathogen Incidents in Transport Hubs	PANDHUB	participant	3.142.004	6
2014-04-01	Mimimally invasive retrograde targeting of aCAR lentiviral vector to non-human primate motor neurons	RTLVNHP	participant	149.526	2
2014-01-01	Tissue engineering of the right heart outflow tract by a biofunctionalized bioresorbable polymeric valved tube	TEH-TUBE	coordinator	4.500.962	7
2014-01-01	Demonstrating Minicare, a miniaturized biophotonics platform for fast and lab-equivalent Point-of-Care diagnostics	Lab2Go	participant	1.915.000	10
2013-12-01	A Phase Ib/II study of MEK1/2 inhibitor PD-0325901 with cMET inhibitor PF-02341066 in KRASMT and KRASWT (with aberrant c-MET) Colorectal Cancer Patients	MERCURIC	participant	5.999.995	13
2013-10-01	Cystic Fibrosis Microbiome-determined Antibiotic Therapy Trial in Exacerbations: Results Stratified.	CFMATTERS	participant	5.999.748	12
2013-10-01	A drug strategy targeting stabilised mutant p53 to fight metastatic platinum-resistant ovarian cancer	GANNET53	participant	5.994.072	18
2013-10-01	Collaborative European NeuroTrauma Effectiveness Research in TBI	CENTER-TBI	participant	29.998.903	38
2013-09-01	Semantics-driven Design through Geo and Building Information Modelling for Energy-efficient Buildings Integrated in Mixed-use Healthcare Districts	STREAMER	participant	8.000.000	20
2013-09-01	Multivessel versus culprit lesion only percutaneous revascularization in patients with acute myocardial infarction complicated by cardiogenic shock	CULPRIT-SHOCK	participant	5.999.145	17
2013-07-01	GAbapentin in Paediatric Pain	GAPP	participant	5.476.875	15
2013-03-01	Biomarkers of renal graft injuries in kidney allograft recipients	BIOMARGIN	participant	6.000.000	13
2013-02-01	Nanomedicine for target-specific imaging and treatment of atherosclerosis: development and initial clinical feasibility	NANOATHERO	participant	9.833.348	16
2013-01-01	Phase I/II Gene Therapy Trial of Fanconi anemia patients with a new Orphan Drug consisting of a lentiviral vector carrying the FANCA gene: A Coordinated International Action	EUROFANCOLEN	participant	5.380.170	11
2012-12-01	A Europe-wide Strategy to enhance Transplantation of highly sensitized patients on basis of Acceptable HLA Mismatches	EUROSTAM	participant	2.623.500	11
2012-12-01	Gene Therapy for X-linked Chronic Granulomatous Disease (CGD)	NET4CGD	participant	5.999.607	11
2012-11-01	Metagenomics in Cardiometabolic Diseases	METACARDIS	participant	11.999.992	15
2012-11-01	"Observational Prolonged Trial In Myotonic dystrophy type 1 to Improve QoL-Standards, a Target Identification Collaboration"	OPTIMISTIC	participant	3.000.000	9

overview shows latest 50 from 144 projects (2000-01-01 - 2018-12-31)
A full list of projects can be found here:

Alias institution names:

ASSISTANCE PUBLIQUE HOPITAUX DE PARIS
ASSISTANCE PUBLIQUEHOPITAUX DE PARIS HOPITAL NECKERENFANTS MALADES
ASSITANCE PUBLIQUE HOPITAUX DE PARIS CIC COCHIN

Data provision: © European Union; Source: CORDIS, http://cordis.europa.eu/ | This page is not provided by the European Commission see:Impressum

Ads: